US 12,139,461 B1
Piperidine compounds as PDE5 inhibitors
Alaa Abdel-Moenes Abdel-Aziz, Riyadh (SA); Adel Shaaban Azab Morsy, Riyadh (SA); and Sabry Mohamed Abdo Attia, Riyadh (SA)
Assigned to KING SAUD UNIVERSITY, Riyadh (SA)
Filed by KING SAUD UNIVERSITY, Riyadh (SA)
Filed on Apr. 22, 2024, as Appl. No. 18/642,707.
Int. Cl. C07D 211/96 (2006.01); A61K 31/451 (2006.01); A61P 15/10 (2006.01); C07D 211/14 (2006.01); C12N 9/99 (2006.01)
CPC C07D 211/96 (2013.01) [A61K 31/451 (2013.01); A61P 15/10 (2018.01); C07D 211/14 (2013.01); C12N 9/99 (2013.01)] 3 Claims
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
a pharmaceutically acceptable salt, ester, stereoisomer, or solvate thereof.